Precision oncology company founded in 2008, headquartered in Irving, Texas. Caris provides comprehensive molecular profiling to guide personalized cancer treatment. Its Caris Molecular Intelligence® platform integrates DNA, RNA, and protein data with AI to support diagnostics and therapeutic decision-making. Caris also develops liquid biopsy assays and large-scale oncology datasets. (carisls.com)...